All Posts

Precision BioLogic Poster at ISTH: DOAC-Remove

You are invited to visit the ISTH poster submitted by Precision BioLogic Inc.: PB1147 Effect of high-dose direct anticoagulant drugs and DOAC-Remove on lupus anticoagulant detection by a hexagonal phase phospholipid assay. The poster goes up Tuesday, 27 June 2023, 18:30–19:30.

Specimen Management

CLN: Viscoelastometry Article

Here is a May 2023 Clinical Laboratory News cover review by colleague and fellow “clotter” Oksana Volod, MD, entitled “Is TEG the Right Assay? [click]” The article describes the updated means for near-patient viscoelastometry assays, whose original methodology became available in 1948. Clinical Laboratory News is a widely distributed American Association for Clinical Chemistry [AACC} […]

Global Hemostasis Assays

Familial APS?

On June 1 a Fritsma Factor participant asked if there were any evidence of a familial prevalence for symptomatic antiphospholipid syndrome [APS] or lab evidence for the familial distribution of one of the antiphospholipid antibodies [APAs]: lupus anticoagulant [LA], anti-cardiolipin antibody [ACA], or anti-beta-2-glycoprotein 1. I [Geo] located only a single case report: Bhattacharya S, […]

Lupus Anticoagulant

June 2023 Cheat Sheet

Here is a copy of your June 2023 cheat sheet. Your personal copy will arrive by email in a few days.

June 2023 Quick Question: Factor VIII Inhibitor Bypass

Our June Quick Question asks, “Name the bispecific antibody-based FVIII inhibitor bypass agent,” and lists several recently released therapeutics that are changing the shape of hemostasis disorder treatment. Please select your answer from the column on the right and add your comments below.

Quick Question Archive

May 2023 Quick Question: DTI

Our May 2023 Quick Question asks, “Which DOAC is a direct thrombin inhibitor? Our 70 respondents chose… Dabigatran [Pradaxa]: 56 [80%] Rivaroxaban [Xarelto]: 3 [4%] Apixaban [Eliquis]: 3 [4%] Warfarin [Coumadin]: 7 [10%] Clopidogrel [Plavix]: [2%] Dabigatran is the direct thrombin inhibitor, whereas rivaroxaban and apixaban are direct anti-Xa inhibitors. Clopidogrel is an antiplatelet antithrombotic. […]

Quick Question Archive

Webinar: The Many Faces of VWF, Part 2: Tumor Progression

Fritsma Factor participants, we invite you to view the next installment of our video series “Coag Conversations:” Dr. E. J. Favaloro: The Many Faces of von Willebrand Factor; or Von Willebrand Factor, ADAMTS13, Malignancy, and Beyond Part 2: Von Willebrand Factor and ADAMTS13: Tumor Progression and Beyond, sponsored by BioMedica Diagnostics, Inc.

Conference Calendar

We updated our Conference Calendar on Saturday, May 13, 2023. Check here for your 2023–24 hemostasis events. Contact me [Geo] at [email protected] to add your event.

PERT Consortium

Thanks to Paul Riley, Ph.D., Diagnostica Stago, for his introduction to the Pulmonary Embolism Response Team [PERT] Consortium. For our list of hemostasis-related links, click here. If your association does not appear in the list, please provide the website and link to me [Geo] at [email protected].

Antiphospholipid Antibodies in Gulf War Syndrome

Thanks to hemostasis researcher Dave McGlasson for sending this article that indicates lupus anticoagulant as an autoimmunity mechanism associated with Gulf War Syndrome. James LM, Johnson RA, Lewis SM, et al. Lupus anticoagulant in Gulf War Illness and autoimmune disorders: a common pathway toward autoimmunity. J Immunological Sci. 2021; 5: 14–18. Dave had published a […]

Load more

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.